CD8A and melanoma: Functional assay using the melanoma mouse model and the human melanoma tissues revealed that NKTR-214 expands, maintaining effector CD8+ T cells and depleting Tregs by effector CD8+ T cell-derived IFN-γ and TNF-α (39, 56).